Immune cells from your own tumor could fight advanced melanoma

NCT ID NCT07288203

Ongoing Disease control Sponsor: Iovance Biotherapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental therapy called lifileucel for people with advanced melanoma that has spread or cannot be removed by surgery and has worsened after standard treatments. About 100 adults will receive their own tumor-fighting immune cells (TILs) grown in a lab. The main goal is to see if the treatment shrinks tumors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MELANOMA (SKIN CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

melanoma metastatic melanoma skin neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MELANOMA (SKIN CANCER) METASTATIC MELANOMA UNRESECTABLE MELANOMA

Contacts and locations

Locations

Centre Hospitalier de l'Universite de Montreal

Montral, Quebec, Canada, H2X 0A9, Canada
Greenslopes Private Hospital

Greenslopes, Queensland, 4120, Australia
Princess Margaret Cancer Centre

Toronto, Ontario, Canada, M5G 2M9, Canada
Royal Marsden Hospital

London, SW3 6JJ, United Kingdom
Sarah Cannon Research Institute

Nashville, Tennessee, 37203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.